New program aims to ease dementia fears in menopausal women
NCT ID NCT06965686
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is developing a short, personalized program called PERI-MIND to help menopausal women who are worried about dementia. The program includes education about menopause and dementia risk, plus practical skills to cope with fear. Researchers will first hold focus groups to understand women's needs, then test the program with 60 women to see if it is acceptable and feasible.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PERI-MIND (behavioral intervention: psychoeducation, psychological grounding, behavioral activation)
What this could lead to
If successful, this could provide a practical, short-term program to help menopausal women cope with dementia fears and adopt healthier behaviors.
What could go wrong
This is a very early pilot study with only 60 participants and no control group. It tests feasibility, not effectiveness, so results may not generalize.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Chicago Medicine
RECRUITINGChicago, Illinois, 60637, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••